BradHRovinMD

PubMed

• Time for Action: Recognising chronic kidney disease as a major non-communicable disease driver of premature mortality.
  Germaine Wong, Amélie Bernier-Jean, Pierre Ronco, , Brad Rovin> ;Kidney International. 2024 Apr 2
• Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis.
  Jürgen Floege, David R W Jayne, Jan-Stephan F Sanders, Vladimír Tesar, Ethan M Balk, Craig E Gordon, Gaelen Adam, Marcello A Tonelli, Michael Cheung, Amy Earley, Brad ...> ;Kidney International. 2024 Mar 1
• 1 citations
  Green nephrology: an editor's journey.
  De Chiara, L., Ronco, P., Rovin, B.> ;Journal of Nephrology. 2024 Jan 1
• 1 citations
  Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial.
  Chakravarty, E., Utset, T., Kamen, D., Contreras, G., McCune, W., Aranow, C., Kalunian, K., Massarotti, E., Clowse, M., Rovin, B., Lim, S., Majithia, V., Dall'Era, M.,...> ;The Lancet. Rheumatology. 2024 Mar 1
• The chromatin landscape of healthy and injured cell types in the human kidney.
  Gisch, D., Brennan, M., Lake, B., Basta, J., Keller, M., Melo Ferreira, R., Akilesh, S., Ghag, R., Lu, C., Cheng, Y., Collins, K., Parikh, S., Rovin, B., Robbins, L., ...> ;Nature Communications. 2024 Jan 10
• 1 citations
  Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis.
  Ayoub, I., Chan, T., Liu, Z., Mejía-Vilet, J., Balk, E., Adam, G., Tonelli, M., Cheung, M., Earley, A., Floege, J., Rovin, B., Gordon, C.> ;Kidney International. 2024 Jan 1
• Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment.
  Mejia-Vilet, J., Turner-Stokes, T., Houssiau, F., Rovin, B.> ;Best Practice & Research. Clinical Rheumatology. 2023 Dec 26
• Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy.
  Tam, F., Tumlin, J., Barratt, J., Rovin, B., Roberts, I., Roufosse, C., Cook, H., Bhangal, G., Brown, A., Busch, M., Dudhiya, F., Duliege, A., Fraser, D., Gale, D., Hu...> ;Kidney International Reports. 2023 Dec 1
• Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial.
  Brad H Rovin, Richard A Furie, Jorge A Ross Terres, Sophia Giang, Thomas Schindler, Armando Turchetta, Jay P Garg, William F Pendergraft 3rd, Ana Malvar> ;Arthritis & Rheumatology. 2024 Feb 1
• 7 citations
  Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
  Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, Charles E Alpers, Stewart Bieler, Dong-Wan Chae, Ulysses A Diva, Jürgen Floege, Loreto Gesualdo, Jula K Inrig, Don...> ;Lancet. 2023 Dec 2
• Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
  Salem Almaani, Huijuan Song, Meshora Suthanthira, Christopher Toy, Lynn A Fussner, Alexa Meara, Haikady Nagaraja, David Cuthbertson, Nader A Khalidi, Curry L Koening, ...> ;Kidney International Reports. 2023 Nov 1
• 6 citations
  Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.
  Hong Zhang, Dana V Rizk, Vlado Perkovic, Bart Maes, Naoki Kashihara, Brad Rovin, Hernán Trimarchi, Ben Sprangers, Matthias Meier, Dmitrij Kollins, Olympia Papachristof...> ;Kidney International. 2024 Jan 1
• 1 citations
  Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients.
  Shudan Wang, Anna Broder, Daming Shao, Vartika Kesarwani, Brianna Boderman, Jennifer Aguilan, Simone Sidoli, Masako Suzuki, John M Greally, Yvonne M Saenger, Brad H Ro...> ;Seminars in Arthritis and Rheumatism. 2023 Dec 1
• Effect of Belimumab on PreventingRenal Lupus Flares.
  Ioannis Parodis, Julius Lindblom, Nursen Cetrez, Leonardo Palazzo, Henri Ala, Frédéric A Houssiau, Christopher Sjöwall, Brad H Rovin> ;Kidney International Reports. 2023 Sep 1
• 13 citations
  Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.
  Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimir Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N Reich, Brad H R...> ;Lancet. 2023 Sep 9
• 1 citations
  Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.
  David Jayne, Brad Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, Jacob Knagenhjelm, Erik Schwetje, Weifeng Tang, Raj Tummala, Catharina Lin...> ;Lupus Science & Medicine. 2023 Aug 1
• 1 citations
  Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
  Sean J Barbour, Fernando C Fervenza, Dilshani Induruwage, Paul E Brenchley, Brad Rovin, Michelle A Hladunewich, Heather N Reich, Richard Lafayette, Nabeel Aslam, Geral...> ;Clinical Journal of the American Society of Nephrology. 2023 Oct 1
• 1 citations
  Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial.
  Hans-Joachim Anders, Richard Furie, Ana Malvar, Ming-Hui Zhao, Keiju Hiromura, Julia Weinmann-Menke, Yulia Green, Angela Jones-Leone, Daniela Negrini, Roger A Levy, Li...> ;Nephrology, Dialysis, Transplantation. 2023 Nov 30
• Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy.
  Alana Dasgupta, Galina Mikhalina, Anjali A Satoskar, Laura Biederman, Tibor Nadasdy, Brad Rovin, Samir Parikh, Sergey V Brodsky> ;Kidney International Reports. 2023 Jul 1
• N-acetylcysteine ameliorates hematuria-associated tubulointerstitial injury in 5/6 nephrectomy mice.
  Ajay Medipally, Min Xiao, Anjali A Satoskar, Laura Biederman, Alana Dasgupta, Iouri Ivanov, Galina Mikhalina, Brad Rovin, Sergey V Brodsky> ;Physiological Reports. 2023 Jul 1
• 9 citations
  IgA nephropathy: the lectin pathway and implications for targeted therapy.
  Jonathan Barratt, Richard A Lafayette, Hong Zhang, Vladimir Tesar, Brad H Rovin, James A Tumlin, Heather N Reich, Jürgen Floege> ;Kidney International. 2023 Aug 1
• 2 citations
  Update on scoring and providing evidence basis for assessing pathology in lupus nephritis.
  Ingeborg M Bajema, James E Balow, Mark Haas, David Jayne, Liz Lightstone, Brad H Rovin, Surya V Seshan, Agnes B Fogo> ;Kidney International. 2023 May 1
• The authors reply.
  Jonathan Barratt, Brad H Rovin> ;Kidney International. 2023 May 1
• 3 citations
  Remission of lupus nephritis: the trajectory of histological response in successfully treated patients.
  Ana Malvar, Valeria Alberton, Bruno Lococo, Maria Lourenco, Joaquin Martinez, Lucrecia Burna, Celeste Besso, Jordi Navarro, Haikady N Nagaraja, Aastha Khatiwada, Betha...> ;Lupus Science & Medicine. 2023 May 1
• The authors reply.
  Jonathan Barratt, Brad H Rovin> ;Kidney International. 2023 May 1
• Join now to see all

Journal Articles

• Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis  
  Richard Furie, Brad H Rovin, The New England Journal of Medicine
• A Randomized, Controlled Double-Blind Study Comparing the Efficacy and Safety of Dose-Ranging Voclosporin with Placebo in Achieving Remission in Patients with Active L...  
  Brad H Rovin, William F Pendergraft, Kidney International
• Peripheral Blood B Cell Depletion After Rituximab and Complete Response in Lupus Nephritis  
  Matthew D Cascino, Jay Garg, Paul Brunetta, Tamiko R Katsumoto, Paul Brakeman, Brad Rovin, Leonard Dragone, Richard John Looney, Journal of the American Society of Nephrology

Lectures

• Case Studies in Glomerular Disease 
  American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
• A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance Therapy 
  American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019

Other

• A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance Therapy 
  Brad Rovin, MD, Kidney International
  https://www.doximity.com/articles/f57e0281-b555-4e34-9cc9-02fdf46f5ce7
  UpToDate, Wolters Kluwer Health - 2013-01-24
• A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance Therapy 
  Brad Rovin, MD, Kidney International
  https://www.doximity.com/articles/f57e0281-b555-4e34-9cc9-02fdf46f5ce7
  UpToDate, Wolters Kluwer Health - 2013-03-06
• A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance Therapy 
  Brad Rovin, MD, Kidney International
  https://www.doximity.com/articles/f57e0281-b555-4e34-9cc9-02fdf46f5ce7
  UpToDate, Wolters Kluwer Health - 2013-01-03
• A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance Therapy 
  Brad Rovin, MD, Kidney International
  https://www.doximity.com/articles/f57e0281-b555-4e34-9cc9-02fdf46f5ce7
  UpToDate, Wolters Kluwer Health - 2012-12-04
• Join now to see all